Angiotensin I and angiotensin II concentrations and their ratio in catecholamine-resistant vasodilatory shock
Open Access
- 6 February 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Critical Care
- Vol. 24 (1), 1-8
- https://doi.org/10.1186/s13054-020-2733-x
Abstract
In patients with vasodilatory shock, plasma concentrations of angiotensin I (ANG I) and II (ANG II) and their ratio may reflect differences in the response to severe vasodilation, provide novel insights into its biology, and predict clinical outcomes. The objective of these protocol prespecified and subsequent post hoc analyses was to assess the epidemiology and outcome associations of plasma ANG I and ANG II levels and their ratio in patients with catecholamine-resistant vasodilatory shock (CRVS) enrolled in the Angiotensin II for the Treatment of High-Output Shock (ATHOS-3) study. We measured ANG I and ANG II levels at baseline, calculated their ratio, and compared these results to values from healthy volunteers (controls). We dichotomized patients according to the median ANG I/II ratio (1.63) and compared demographics, clinical characteristics, and clinical outcomes. We constructed a Cox proportional hazards model to test the independent association of ANG I, ANG II, and their ratio with clinical outcomes. Median baseline ANG I level (253 pg/mL [interquartile range (IQR) 72.30–676.00 pg/mL] vs 42 pg/mL [IQR 30.46–87.34 pg/mL] in controls; P < 0.0001) and median ANG I/II ratio (1.63 [IQR 0.98–5.25] vs 0.4 [IQR 0.28–0.64] in controls; P < 0.0001) were elevated, whereas median ANG II levels were similar (84 pg/mL [IQR 23.85–299.50 pg/mL] vs 97 pg/mL [IQR 35.27–181.01 pg/mL] in controls; P = 0.9895). At baseline, patients with a ratio above the median (≥1.63) had higher ANG I levels (P < 0.0001), lower ANG II levels (P < 0.0001), higher albumin concentrations (P = 0.007), and greater incidence of recent (within 1 week) exposure to angiotensin-converting enzyme inhibitors (P < 0.00001), and they received a higher norepinephrine-equivalent dose (P = 0.003). In the placebo group, a baseline ANG I/II ratio P = 0.01) on unadjusted analyses. Patients with CRVS have elevated ANG I levels and ANG I/II ratios compared with healthy controls. In such patients, a high ANG I/II ratio is associated with greater norepinephrine requirements and is an independent predictor of mortality, thus providing a biological rationale for interventions aimed at its correction. ClinicalTrials.gov identifier NCT02338843. Registered 14 January 2015.Keywords
Funding Information
- La Jolla Pharmaceutical Company (N/A)
This publication has 29 references indexed in Scilit:
- Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care MedicineIntensive Care Medicine, 2014
- Severe sepsis: Low expression of the renin-angiotensin system is associated with poor prognosisExperimental and Therapeutic Medicine, 2014
- Circulatory ShockThe New England Journal of Medicine, 2013
- Therapeutic Strategies for High-Dose Vasopressor-Dependent ShockCritical Care Research and Practice, 2013
- Survival After Shock Requiring High-Dose Vasopressor TherapySocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2013
- Adverse cardiac events during catecholamine vasopressor therapy: a prospective observational studyIntensive Care Medicine, 2012
- Does dopamine administration in shock influence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) Study*Critical Care Medicine, 2006
- Downregulation of Angiotensin-Converting Enzyme by Tumor Necrosis Factor-α and Interleukin-1β in Cultured Human Endothelial CellsJournal of Vascular Research, 2001
- Effects of captopril related to increased levels of prostacyclin and angiotensin-(1-7) in essential hypertensionJournal of Hypertension, 1996
- Additive Effects of Combined Angiotensin-Converting Enzyme Inhibition and Angiotensin II Antagonism on Blood Pressure and Renin Release in Sodium-Depleted NormotensivesJournal of the American College of Cardiology, 1995